| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Vera Therapeutics, Inc. (VERA) have been net sellers, shedding 37,000 shares worth roughly $1.3M on balance.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 235.2K | $7.22M | - | |
| CFO | 114.2K | $3.51M | - | |
| VP | 80.8K | $2.48M | - | |
| Other | 64.2K | $1.97M | - | |
| Other | 50.9K | $1.56M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 14, 2022 | Joanne Curley69 | Chief Development Officer | Sale+OE | 9,104 | $15.14 | $137,863.71 | -33.3% | +28.9% | +9.4% | |
| Jul 7, 2022 | Joanne Curley69 | Chief Development Officer | Sale+OE | 9,666 | $15.05 | $145,453.39 | -31.5% | +40.4% | +7.2% | |
| Jun 22, 2022 | Joanne Curley69 | Chief Development Officer | Sale+OE | 1,545 | $15.01 | $23,197.95 | -6.1% | +47.0% | +10.8% | |
| Jun 17, 2022 | Joanne Curley69 | Chief Development Officer | Sale+OE | 5,887 | $15.04 | $88,565.49 | -19.7% | +53.5% | -7.5% | |
| Jun 15, 2022 | Sean Grant56 | Chief Financial Officer | Buy | 5,000 | $13.60 | $68,004.00 | -124.8% | +49.4% | -9.1% | |
| May 31, 2022 | Joanne Curley69 | Chief Development Officer | Sale+OE | 400 | $15.22 | $6,086.20 | -1.6% | +50.1% | -42.6% | |
| Feb 10, 2022 | Sofinnova Venture Partners X, L.P.55 | 10% Owner | Buy | 266,666 | $15.00 | $3,999,990.00 | +9.1% | -14.9% | -58.0% | |
| Feb 10, 2022 | Longitude Capital Partners IV, LLC63 | 10% Owner | Buy | 333,333 | $15.00 | $4,999,995.00 | +10.8% | -14.9% | -58.0% | |
| Feb 10, 2022 | Patrick G Enright71 | Director, 10% Owner | Buy | 333,333 | $15.00 | $4,999,995.00 | +10.8% | -14.9% | -58.0% | |
| Feb 6, 2022 | Joseph R Young61 | SVP, Finance, Chief Acct Officer | Buy | 5,714 | $7.00 | $39,998.00 | +33.7% | -9.1% | -65.8% |